Replicate Crossover Designs in BA/BE Studies: When and Why to Use Them
Replicate Crossover Designs in BA/BE Studies: When and Why to Use Them Understanding Replicate Crossover Designs in Bioequivalence Trials Introduction: Addressing Complexity in Bioequivalence with Replicate Designs Bioequivalence (BE) studies are essential in establishing the interchangeability of generic and innovator drug products. While standard two-period, two-sequence crossover designs are common in BA/BE studies, they may…
Read More “Replicate Crossover Designs in BA/BE Studies: When and Why to Use Them” »